{"disease":{"id":"alopecia-areata-aa","name":"alopecia areata aa"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07101471","title":"Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":296,"lead_sponsor_name":"NanoAlvand","has_results":false},{"nct_id":"NCT04445363","title":"A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Suzhou Zelgen Biopharmaceuticals Co.,Ltd","has_results":false},{"nct_id":"NCT07455708","title":"Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT07499713","title":"Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":90,"lead_sponsor_name":"Istanbul Training and Research Hospital","has_results":false},{"nct_id":"NCT06786689","title":"To Compare the Efficacy of Weekly Azathioprine Pulse Versus Betamethasone Oral Mini-Pulse in the Treatment of Moderate to Severe Alopecia Areata","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Sheikh Zayed Medical College","has_results":false},{"nct_id":"NCT07381556","title":"Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT07049328","title":"HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"HCW Biologics","has_results":false},{"nct_id":"NCT06799520","title":"A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT06060977","title":"A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Inmagene LLC","has_results":true}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}